[go: up one dir, main page]

SI9200404A - Pharmaceutical composition and process for the preparation thereof - Google Patents

Pharmaceutical composition and process for the preparation thereof Download PDF

Info

Publication number
SI9200404A
SI9200404A SI9200404A SI9200404A SI9200404A SI 9200404 A SI9200404 A SI 9200404A SI 9200404 A SI9200404 A SI 9200404A SI 9200404 A SI9200404 A SI 9200404A SI 9200404 A SI9200404 A SI 9200404A
Authority
SI
Slovenia
Prior art keywords
inhibitor
phenyl
preparation
mao
preparation according
Prior art date
Application number
SI9200404A
Other languages
English (en)
Slovenian (sl)
Inventor
Kalman Magyar
Jozsef Gaal
Istvan Sziraki
Jozsef Lengyel
Anna Z Szabo
Katalin Marmarosi
Istvan Hermecz
Istvan Szatmari
Zoltan Toeroek
Peter Koermoeczy
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of SI9200404A publication Critical patent/SI9200404A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI9200404A 1991-12-20 1992-12-18 Pharmaceutical composition and process for the preparation thereof SI9200404A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU914060A HUT63579A (en) 1991-12-20 1991-12-20 Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes

Publications (1)

Publication Number Publication Date
SI9200404A true SI9200404A (en) 1993-06-30

Family

ID=10966728

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9200404A SI9200404A (en) 1991-12-20 1992-12-18 Pharmaceutical composition and process for the preparation thereof

Country Status (27)

Country Link
US (1) US5589513A (fr)
EP (1) EP0617615A1 (fr)
JP (1) JPH07502730A (fr)
KR (1) KR940703655A (fr)
AU (1) AU677170B2 (fr)
BG (1) BG98827A (fr)
BR (1) BR9206950A (fr)
CA (1) CA2125776A1 (fr)
CZ (1) CZ147494A3 (fr)
EC (1) ECSP930933A (fr)
EE (1) EE03015B1 (fr)
FI (1) FI942932A7 (fr)
HU (2) HUT63579A (fr)
IL (1) IL104150A (fr)
LT (1) LT3119B (fr)
LV (1) LV10386B (fr)
MY (1) MY111055A (fr)
NO (1) NO942303D0 (fr)
NZ (1) NZ246384A (fr)
PH (1) PH31073A (fr)
PL (1) PL172048B1 (fr)
RO (1) RO115785B1 (fr)
RU (1) RU2125448C1 (fr)
SI (1) SI9200404A (fr)
SK (1) SK74494A3 (fr)
WO (1) WO1993012775A1 (fr)
ZA (1) ZA929883B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
DE4432610C1 (de) * 1994-09-13 1996-02-01 Knoll Ag Verfahren zur Herstellung von Selegilin-Hydrochlorid
CA2212412A1 (fr) * 1995-02-10 1996-08-15 The University Of Toronto Innovations Foundation Composes deprenyle pour le traitement du glaucome
JP4499208B2 (ja) 1998-10-29 2010-07-07 株式会社フジモト・コーポレーション 新規な光学活性アミノペンタン誘導体
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
HUP9902482A2 (hu) * 1999-07-22 2002-04-29 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. P-fluoro-selegilin alkalmazása neuroprotektív gyógyszerkészítmények előállítására
RU2194983C2 (ru) * 2000-06-30 2002-12-20 Научно-исследовательский институт военной медицины Способ оценки нейротоксичности сыворотки крови больных с заболеваниями печени
EP2053033A1 (fr) * 2007-10-26 2009-04-29 Bayer Schering Pharma AG Composants à utiliser dans l'imagerie, le diagnostic et/ou le traitement des maladies du système nerveux central ou des tumeurs
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
DE102009045056A1 (de) * 2009-09-28 2011-03-31 Henkel Ag & Co. Kgaa Fleckenvorbehandlungsmittel
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Esters de (17-β)-hydroxy-4-androstène-3-one biodisponibles à l'état solide
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
CA3107214A1 (fr) 2018-07-20 2020-01-23 Lipocine Inc. Maladie du foie

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity
HU207282B (en) * 1984-05-31 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them
EP0241809B1 (fr) * 1986-04-16 1990-08-08 ASTA Pharma Aktiengesellschaft Association synergétique d'amantadine et de sélégiline
HU207280B (en) * 1986-09-25 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them
HU197510B (en) * 1986-12-19 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
CA2037178A1 (fr) * 1990-02-28 1991-08-29 Albert Walter Brzeczko Composition pharmaceutique a base de deprenyl/l-dopa/carbidopa
GB9011767D0 (en) * 1990-05-25 1990-07-18 Britannia Pharmaceuticals Ltd Pharmaceutical compositions
US5169868A (en) * 1991-03-01 1992-12-08 University Of Saskatchewan Aliphatic propargylamines as specific mao-b inhibitors
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
HU209605B (en) * 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
US5326770A (en) * 1992-07-17 1994-07-05 The Du Pont Merck Pharmaceutical Company Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals

Also Published As

Publication number Publication date
NO942303L (fr) 1994-08-17
SK74494A3 (en) 1995-01-12
ECSP930933A (es) 1994-04-20
LT3119B (en) 1994-12-27
HUT63579A (en) 1993-09-28
EP0617615A1 (fr) 1994-10-05
ZA929883B (en) 1994-05-16
EE03015B1 (et) 1997-08-15
HU914060D0 (en) 1992-03-30
NZ246384A (en) 1996-02-27
WO1993012775A1 (fr) 1993-07-08
BG98827A (bg) 1995-06-30
FI942932L (fi) 1994-06-17
MY111055A (en) 1999-08-30
RU2125448C1 (ru) 1999-01-27
JPH07502730A (ja) 1995-03-23
HU211478A9 (en) 1995-11-28
NO942303D0 (no) 1994-06-17
LV10386B (en) 1995-12-20
US5589513A (en) 1996-12-31
AU677170B2 (en) 1997-04-17
AU3265293A (en) 1993-07-28
PL172048B1 (pl) 1997-07-31
LTIP249A (en) 1994-07-15
CZ147494A3 (en) 1995-01-18
RO115785B1 (ro) 2000-06-30
IL104150A (en) 1997-11-20
FI942932A0 (fi) 1994-06-17
LV10386A (lv) 1995-02-20
FI942932A7 (fi) 1994-06-17
CA2125776A1 (fr) 1993-07-08
PH31073A (en) 1998-02-05
KR940703655A (ko) 1994-12-12
BR9206950A (pt) 1995-11-28

Similar Documents

Publication Publication Date Title
SI9200404A (en) Pharmaceutical composition and process for the preparation thereof
EP0464084B1 (fr) Emploi d'acide eicosapentaeno que dans le traitement de la cachexie
US5457130A (en) Eicosapentaenoic acid used to treat cachexia
KR960000430B1 (ko) 산화에 안정한 약제 조성물
EP2892518B1 (fr) Nouvelles approches thérapeutiques pour le traitement de la maladie de parkinson
BG63708B1 (bg) Лекарствени форми на трамадол
RS66566B1 (sr) Farmaceutska kombinacija i kompozicija, i kombinovani preparat koji sadrži aktivator glukokinaze i biguanid hipoglikemijski lek kao i postupak njihove pripreme i upotrebe
FI86689B (fi) Foerfarande foer framstaellning av en multipel-unit-doskomposition, som innehaoller l-dopa som farmaceutiskt aktiv substans.
CN107106521B (zh) 用于治疗帕金森病的治疗方法
RU2642962C2 (ru) Терапия болезни паркинсона с применением комбинации с фиксированными дозами
EP0630250A1 (fr) Compositions pharmaceutiques contenant du monosialoganglioside gm 1? ou un derive de celui-ci, convenant ou traitement de la maladie de parkinson
WO2022200402A1 (fr) Formulation par voie orale d'ivermectine et utilisations
US3360434A (en) Method for reducing blood pressure with phenylalanine derivatives
US4046917A (en) Method of treating migraine
US4645770A (en) Agent for treating Parkinson's disease or Parkinsonism
JPH09500375A (ja) パーキンソン病の治療を目的とする医薬品の製造のためのエファロキサンおよびその誘導体の使用
US3737541A (en) Methods for the treatment of parkinsonism
US3772440A (en) Method for the treatment of parkinsonism and depression
BE1000087A3 (fr) Compositions pharmaceutiques contenant de la vinburnine et leur procede de preparation.
US8962020B2 (en) Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid
KR20030056474A (ko) 카르비도파/레보도파 서방정의 조성물과 그의 제조방법
MXPA00006353A (en) Remedy for neurodegenerative diseases___________________________
BE825194A (fr) Hydrazide de n-benzene-sulfonyl-beta-alanine comme agent immunosupressif sur et actif
JPH0346471B2 (fr)